• Drivers Of Cost-Effectiveness In Type-2 Diabetes Mellitus

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Cognitive-Behavioral Therapy And Physical Exercise For Alleviating Treatment-Induced Menopausal Symptoms In Breast Cancer Patients

    May 1, 2013, 00:00

  • Psychometric performance of the nei VFQ-25- recommendations for a modified version of the 25-item national eye institute questionnaire (NEI VFQ-25) based on rasch analysis using clinical trials data across four retinal diseases

    May 1, 2013, 00:00

  • Budget impacts of potential modification of risk factors for heart failure hospitalizations- a contemporary medicaid cohort analysis

    May 1, 2013, 00:00

  • Melanoma health care pathways in an italian population

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Posaconazole Versus Fluconazole Or Itraconazole In The Prevention Of Invasive Fungal Infections Among Neutropenic Patients In The United States

    May 1, 2013, 00:00

  • Impact Of Oral Medication Adherence And Lab Testing On Five-Year Total Medical Costs In A Commercially Insured Diabetic Population

    May 1, 2013, 00:00

  • Treatment of peripheral neuropathic pain with the capsaicin 8% patch- An observational, real-world study in six European countries

    May 1, 2013, 00:00

  • Prediction of mortality in the presence of time-depended covariates- An application for health ecomonic projections

    May 1, 2013, 00:00

  • Does device matter and at what cost? real-world comparative study of insulin glargine treatment using disposable pen versus vial/syringe in medicaid patients with type-2 diabetes mellitus

    May 1, 2013, 00:00

  • The Cost And Productivity Consequences Of Non-Severe Hypoglycaemic Episodes (Nshe) In Patients Treated With Sulfonylurea Or Dpp4 Dual Combination Oral Therapy

    May 1, 2013, 00:00

  • Second-Line Therapy In Children With Asthma In Colombia- An Economic Evaluation To Inform The National Guideline

    May 1, 2013, 00:00

  • Content validity of the actionable bladder symptom screening tool (ABSST) in non-diabetic females with overactive bladder (OAB) and urgency urinary incontinence (UUI)

    May 1, 2013, 00:00

  • Variation In The Use Of Inhaled Respiratory Medications For Preterm Infants With Bronchopulmonary Dysplasia

    May 1, 2013, 00:00

  • Multiple Sclerosis Increases The Risk Of Infections Resulting In A Hospitalization Among Veterans

    May 1, 2013, 00:00

  • Comparison Of Diagnosis Based Comorbidity Indices To Predict High Cost Copd Patients Prospectively

    May 1, 2013, 00:00

  • Determining An Optimal Pricing Strategy For International Differential Pricing- A Theoretic Macroeconomic Approach

    May 1, 2013, 00:00

  • Changes in health care utilizations and provider specialty due to hurricane katrina on epilepsy patients in the louisiana medicaid population

    May 1, 2013, 00:00

  • Patient Outcomes Of Hip Resurfacing Compared To Total Hip Arthroplasty- A Systematic Review

    May 1, 2013, 00:00

  • Content validity of the facit-fatigue in patients with iron deficiency anemia

    May 1, 2013, 00:00

  • Results from a D-efficient discrete choice experiment design and protocol with choice sets of 3 states each to elicit an EQ-5D-3L value set

    May 1, 2013, 00:00

  • Antifungal Treatment Patterns And Outcomes In Patients With A Blood Culture Positive For Candida And With Sepsis Or Critical Illness

    May 1, 2013, 00:00

  • A Cross Sectional Assessment Of Knowledge Towards Diabetes Mellitus Among Urban Poor Population Of Penang, Malaysia

    May 1, 2013, 00:00

  • The economic burden of chronic kidney disease in China

    May 1, 2013, 00:00

  • Cost analysis of kidney trasplantation with different tratment alternatives at different stages within the mexican public health care system

    May 1, 2013, 00:00

  • Economic modeling in hiv for maraviroc in tretament-naive patients in the united states – Results from the aramis-mvc 2012 model

    May 1, 2013, 00:00

  • Costs Of Adult Immunization Paid In Different Settings

    May 1, 2013, 00:00

  • Achieving Formulary (Drug List) Access And Utilization Of Oncology Drugs In China

    May 1, 2013, 00:00

  • Consequences of the reduction of alcohol consumption on patient's reported outcomes with the use of nalmefene

    May 1, 2013, 00:00

  • Multicomponent Home-Based Environmental Interventions Are Effective In Reducing Morbidity Of Children With Asthma From Low Income Families

    May 1, 2013, 00:00

  • Estimated public health impact of nationwide vaccination of infants with 7-valent pneumococcal conjugate vaccine (pcv7) in China

    May 1, 2013, 00:00

  • Change In Patient-Reported Outcomes During The First Year Post-Diagnosis Of Multiple Myeloma

    May 1, 2013, 00:00

  • Prevalence Of Anti-Diabetic And Antilipidemic Medications In Children And Adolescents Treated With Atypical Antipsychotics In A Virginia Medicaid Population

    May 1, 2013, 00:00

  • Assessing the impact of a medicaid prior authorization (PA) policy for duloxetine on antipsychotic use among patients with depression

    May 1, 2013, 00:00

  • Exploring The Real World Setting Of Chronic Kidney Disease Patient And Physician Behaviors Across Countries- Disease-Specific Programmes

    May 1, 2013, 00:00

  • An Exploratory Analysis Of The Benefits And Costs Of A National Campaign To Promote Colorectal Cancer Screening – Cdc's Screen For Life- National Colorectal Cancer Action Campaign

    May 1, 2013, 00:00

  • Prevalence of commercially insured acupuncture and chiropractic use among patients with chronic inflammation or pain diagnoses

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Ipilimumab In Previously Treated Patients For Advanced Melanoma In Portugal

    May 1, 2013, 00:00

  • Patient-Reported Outcomes (Pros) In Diabetes Clinical Trials

    May 1, 2013, 00:00

  • Construct validity of the SF-12 in type-1 diabetes

    May 1, 2013, 00:00

  • The challenge of accessing orphan drugs in the Middle East- A critical review

    May 1, 2013, 00:00

  • The Cost-Effectiveness Of Hepatitis B Vaccination Using Heplisav Versus Engerix-B In Select Adult Populations In The United States

    May 1, 2013, 00:00

  • Perceptions of individuals living with spinal cord injury toward preference-based quality of life instruments- A qualitative exploration

    May 1, 2013, 00:00

  • A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder

    May 1, 2013, 00:00

  • Suplementary Health Care Utilization Research In Brazil- Characterization Of The BI.2IM Database

    May 1, 2013, 00:00

  • Assessment Of The Mechanisms Of Action Of New Pharmaceuticals Approved By The FDA Between 1980 And 2011

    May 1, 2013, 00:00

  • Impact Of Culture On The Quality Of Life Of Mexican-American Family Caregivers Of Patients With Advanced Cancer

    May 1, 2013, 00:00

  • Treatment Patterns And Costs Of Patients With Gastrointestinal Stromal Tumor (Gist) Receiving First-Line Imatinib

    May 1, 2013, 00:00

  • Skeletal-Related Events And Mortality Among Seer-Medicare Patients With Metastatic Prostate Cancer- The Implications Of Measurement Approach

    May 1, 2013, 00:00

  • Cost-effectiveness of new oral anticoagulants for patients with atrial fibrillation – a decision analysis

    May 1, 2013, 00:00

  • Meta-analysis for efficacy of Romiplostim for treatment of immune idiopathic thrombocytopenia

    May 1, 2013, 00:00

  • Health State Utilities Values For Post-Menopausal Women From The Women's Health Initiative Estrogen+Progestin Clincial Trial

    May 1, 2013, 00:00

  • Economic Assessment Of High-Risk Versus Universal Pediatric Pcv13 Vaccination Programs In Costa Rica

    May 1, 2013, 00:00

  • Using Phone Triage With Risk Stratification To Initiate Low Back Pain Care Within A Health Care System

    May 1, 2013, 00:00

  • Cost Effectiveness Analysis Of Medical Management Of Incomplete Miscarriages In The Bahamas

    May 1, 2013, 00:00

  • An integrated analysis of relapses requiring intravenous steroid use and multiple sclerosis (MS)-related hospitalizations from the BG-12 (dimethyl fumarate) phase 3 define and confirm studies

    May 1, 2013, 00:00

  • Identifying patient subpopulations in early development to substantiate value

    May 1, 2013, 00:00

  • Cost-effectiveness of ticagrelor versus generic clopidogrel in patients with acute coronary syndromes in Canada

    May 1, 2013, 00:00

  • Cost Effectiveness Analysis Of Abiraterone Acetate As Treatment For Metastatic Castration Resistant Prostate Cancer After Failure Of Docetaxel Using Data From Real Life Treatment Praxis In Sweden

    May 1, 2013, 00:00

  • Comparative analysis of drug use in the ambulatory setting among the elderly medicare beneficiaries with alzheimer's disease using different public use files

    May 1, 2013, 00:00

  • Medication adherence for clozapine versus other second-generation antipsychotic drugs in patients with schizophrenia

    May 1, 2013, 00:00

  • Longitudinal relationship between perceived health, functional limitations and work disability in germany and UK

    May 1, 2013, 00:00

  • Antiretroviral Adherence Among Medicaid-Insured Hiv Patients Initiating Current Guideline-Preferred Antiretroviral Therapy Regimens

    May 1, 2013, 00:00

  • Cancer Drug Pricing Trends In The United States And The United Kingdom (2011-2013)

    May 1, 2013, 00:00

  • Use Of Biologically Based Therapies (Bbts) And Assessment Of Health Related Quality Of Life (Hrqol) Among Malaysian Cancer Patients

    May 1, 2013, 00:00

  • Economic Considerations For Mid-Urethral Sling Procedures Among Patients With Stress Urinary Incontinence

    May 1, 2013, 00:00

  • Costs Of Chemotherapy In Hospital And Office-Based Settings- Policy Implications For Cancer Cost Control

    May 1, 2013, 00:00

  • Asthma Control And Frequent Mental Distress (Fmd) In Adults With Active Asthma

    May 1, 2013, 00:00

  • Cost Analysis Of Antibiotics Utilization In Respiratory Tract Infection Using Prescribing Indicators

    May 1, 2013, 00:00

  • Quantification Of Benefits And Risks In Medical Imaging Testing- A Literature Review

    May 1, 2013, 00:00

  • Effect Of Ascorbic Acid On Blood Lead Levels Among School Going Adolescents In Karachi- A Cluster Randomized Trial

    May 1, 2013, 00:00

  • Annual Mortality In A Large Prevalence-Based Sample Of United States Rheumatoid Arthritis Patients

    May 1, 2013, 00:00

  • Bayesian mixed treatment comparison (MTC)- A novel method to demonstrate equivalence and non-inferiority

    May 1, 2013, 00:00

  • Dose relativity of sevelamer hydrochloride and lanthanum carbonate under real-world conditions- Implications for management of patients with end-stage renal disease and hyperphosphatemia

    May 1, 2013, 00:00

  • Cost Of Outbreak Of Meningococcal Disease In A Colombian Caribbean City, 2012

    May 1, 2013, 00:00

  • Using the quality of health economic studies instrument to assess pharmacoeconomic studies evaluating recent food and drug administration drug approvals

    May 1, 2013, 00:00

  • National trends in psychotropic medications use among children with attention deficit hyperactivity disorder (ADHD) in the United States

    May 1, 2013, 00:00

  • Medication Use Survey Of Inpatients With Basic Medical Insurance From 2009 To 2010

    May 1, 2013, 00:00

  • Generating distributions and data- evaluating online, freeware options for health economic models

    May 1, 2013, 00:00

  • The effect of redesigned computerized drug-drug interaction alerts on medication errors and prescribing efficiency

    May 1, 2013, 00:00

  • Cost-Effectiveness And Cost-Utility Analyses Of Fixed-Dose Combination Of Naproxen And Esomeprazole Magnesium For Osteoarthritis Patients At Risk Of Developing Gastric Or Duodenal Ulcer

    May 1, 2013, 00:00

  • Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients- A retrospective cost analysis

    May 1, 2013, 00:00

  • Health-related quality of life (HRQOL) in colorectal cancer patients who finish their treatment in a tertiary hospital

    May 1, 2013, 00:00

  • Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics

    May 1, 2013, 00:00

  • Association between cardiovascular biomarkers levels and cigarette smoking among current smokers, past smokers and non smokers using nhanes 2007-2010

    May 1, 2013, 00:00

  • Determining the current state-of-play for variants of the ‘short form' health-related quality of life instrument in spinal cord injury- A systematic literature review

    May 1, 2013, 00:00

  • Time and motion study design- Handling variability and confounding of results

    May 1, 2013, 00:00

  • Trend In Economic Burden Of Diabetes In Urban China From 2009 To 2011

    May 1, 2013, 00:00

  • Examination Of University Students' Intention To Utilize Emergency Contraception Using The Theory Of Planned Behavior

    May 1, 2013, 00:00

  • A Qualitative Exploration Of Perceptions Towards Pharmaceutical Price War Among Community Pharmacies In The State Of Penang, Malaysia

    May 1, 2013, 00:00

  • Burden Of Disease Of Osteoarthritis In Russia- Results From 2011 National Health And Wellness Survey (Nhws)

    May 1, 2013, 00:00

  • Cost-Effectiveness of a Program to Eliminate Disparities in Pneumococcal Vaccination Rates in Elderly Minority Populations- An Exploratory Analysis

    Mar 1, 2013, 00:00

  • Assessing the Determinants of the Potential for Cost-Effectiveness Over Time- The Empirical Case of COPD

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of a Novel SIAscopic Diagnostic Aid for the Management of Pigmented Skin Lesions in Primary Care- A Decision-Analytic Model

    Mar 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Early versus Late Total Hip Replacement in Italy

    Mar 1, 2013, 00:00

  • Table of Contents

    Mar 1, 2013, 00:00

  • Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States

    Mar 1, 2013, 00:00

  • Patient Preferences for Biologic Agents in Rheumatoid Arthritis- A Discrete-Choice Experiment

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of Enhancing Adherence to Therapy with Blood Pressure–Lowering Drugs in the Setting of Primary Cardiovascular Prevention

    Mar 1, 2013, 00:00

  • Instructions for Authors

    Mar 1, 2013, 00:00

  • Economic Measurement of Medical Errors Using a Hospital Claims Database

    Mar 1, 2013, 00:00

  • Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy

    Mar 1, 2013, 00:00

  • Hospitalization Resource Use and Costs Before and After TIA and Stroke- Results from a Population-Based Cohort Study (OXVASC)

    Mar 1, 2013, 00:00

  • Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer- A Network Meta-Analysis with Parametric Survival Models

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer

    Mar 1, 2013, 00:00

  • The Comparison of Trial Data–Based and Registry Data–Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain- A US Private Payer Perspective

    Mar 1, 2013, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration- A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

    Mar 1, 2013, 00:00

  • An Expert on Every Street Corner? Methods for Eliciting Distributions in Geographically Dispersed Opinion Pools

    Mar 1, 2013, 00:00

  • Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire Scores in Patients with Colorectal Cancer

    Mar 1, 2013, 00:00

  • Erratum

    Mar 1, 2013, 00:00

  • Response about Rank Reversal

    Mar 1, 2013, 00:00

  • Editorial Board

    Mar 1, 2013, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

    Mar 1, 2013, 00:00

  • Improving the Quality of Papers Published in Pharmacoeconomics and Outcomes Research

    Mar 1, 2013, 00:00

  • Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder

    Mar 1, 2013, 00:00

  • Copyright/Subscription

    Mar 1, 2013, 00:00

  • Quality of Life in the First 6 Weeks Following Laparoscopic and Open Colorectal Surgery

    Mar 1, 2013, 00:00

  • Evaluating the Impact of Unmeasured Confounding with Internal Validation Data- An Example Cost Evaluation in Type 2 Diabetes

    Mar 1, 2013, 00:00

  • Evidence Synthesis Assumes Additivity on the Scale of Measurement- Response to “Rank Reversal in Indirect Comparisons” by Norton et al.

    Mar 1, 2013, 00:00

  • Need for Speed- An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information

    Mar 1, 2013, 00:00

  • Understanding the Costs of Care for Cystic Fibrosis- An Analysis by Age and Health State

    Mar 1, 2013, 00:00

  • Economic Efficiency of Countries’ Clinical Review Processes and Competitiveness on the Market of Human Experimentation

    Jan 1, 2013, 00:00

  • Consumer Preferences for Health and Nonhealth Outcomes of Health Promotion- Results from a Discrete Choice Experiment

    Jan 1, 2013, 00:00

  • The Importance of Values in Shaping How Health Systems Governance and Management Can Support Universal Health Coverage

    Jan 1, 2013, 00:00

  • Transparent Interactive Decision Interrogator—Reply to Letter to the Editor by Michael Coory

    Jan 1, 2013, 00:00

  • Editorial Board

    Jan 1, 2013, 00:00

  • Multidomain Patient-Reported Outcomes of Irritable Bowel Syndrome- Exploring Person-Centered Perspectives to Better Understand Symptom Severity Scores

    Jan 1, 2013, 00:00

  • Reviewer Acknowledgment

    Jan 1, 2013, 00:00

  • Sustaining Universal Health Coverage- The Interaction of Social, Political, and Economic Sustainability

    Jan 1, 2013, 00:00

  • A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework

    Jan 1, 2013, 00:00

  • Editorial Board

    Jan 1, 2013, 00:00

  • Which Health-Related Quality-of-Life Outcome When Planning Randomized Trials- Disease-Specific or Generic, or Both? A Common Factor Model

    Jan 1, 2013, 00:00

  • Turning the Spotlight on Experimental Design in Discrete Choice Experiments—A Focus on Pragmatic Approaches in Health

    Jan 1, 2013, 00:00

  • Binary Choice Health State Valuation and Mode of Administration- Head-to-Head Comparison of Online and CAPI

    Jan 1, 2013, 00:00

  • Instructions for Authors

    Jan 1, 2013, 00:00

  • Responsiveness of the EQ-5D Health-Related Quality-of-Life Instrument in Assessing Low Back Pain

    Jan 1, 2013, 00:00

  • TIDI Addresses Uncertainty But Not Indeterminism

    Jan 1, 2013, 00:00

  • Table of Contents

    Jan 1, 2013, 00:00

  • Core Domains for a Person-Focused Outcome Measurement System in Cancer (PROMS-Cancer Core) for Routine Care- A Scoping Review and Canadian Delphi Consensus

    Jan 1, 2013, 00:00

  • Is Management Essential to Improving the Performance and Sustainability of Health Care Systems and Organizations? A Systematic Review and a Roadmap for Future Studies

    Jan 1, 2013, 00:00

  • Copyright/Subscription

    Jan 1, 2013, 00:00

  • Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

    Jan 1, 2013, 00:00

  • Instructions for Authors

    Jan 1, 2013, 00:00

  • Universal Health Coverage- A Quest for All Countries But under Threat in Some

    Jan 1, 2013, 00:00

  • The Effects of Diabetes, Hypertension, Asthma, Heart Disease, and Stroke on Quality-Adjusted Life Expectancy

    Jan 1, 2013, 00:00

  • Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine- Results from the American Migraine Prevalence and Prevention (AMPP) Study

    Jan 1, 2013, 00:00

  • Detecting Changes in Patient Treatment Satisfaction with Medicines- The SATMED-Q

    Jan 1, 2013, 00:00

  • Code of Ethics

    Jan 1, 2013, 00:00

  • Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program

    Jan 1, 2013, 00:00

  • Table of Contents

    Jan 1, 2013, 00:00

  • Rejoinder to Commentary- When Mapping Treatment Effects from Disease-Specific to Generic Scales, Ordinary Least Squares Regression Underestimates the Benefits of Treatment

    Jan 1, 2013, 00:00

  • Setting the Scene- The Challenges of Universal Health Coverage and the Contribution of Management Education

    Jan 1, 2013, 00:00

  • Some Comments on Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales

    Jan 1, 2013, 00:00

  • Assessing the Impact of Privatizing Public Hospitals in Three American States- Implications for Universal Health Coverage

    Jan 1, 2013, 00:00

  • Constructing Experimental Designs for Discrete-Choice Experiments- Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

    Jan 1, 2013, 00:00

  • Using Resource Use Logs to Reduce the Amount of Missing Data in Economic Evaluations Alongside Trials

    Jan 1, 2013, 00:00

  • Assessing the Added Value of Health Technologies- Reconciling Different Perspectives

    Jan 1, 2013, 00:00

  • Cost-Effectiveness of Interventions for Reducing Road Traffic Injuries Related to Driving under the Influence of Alcohol

    Jan 1, 2013, 00:00

  • The International Society for Pharmacoeconomics and Outcomes Research

    Jan 1, 2013, 00:00

  • Adding Decision Models to Systematic Reviews- Informing a Framework for Deciding When and How to Do So

    Jan 1, 2013, 00:00

  • Understanding the Impact of Global Trade Liberalization on Health Systems Pursuing Universal Health Coverage

    Jan 1, 2013, 00:00

  • ERRATUM

    Jan 1, 2013, 00:00

  • Universal Health Coverage—Big Thinking versus Big Data

    Jan 1, 2013, 00:00

  • An International Survey of the Public Engagement Practices of Health Technology Assessment Organizations

    Jan 1, 2013, 00:00

  • The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer- A Health Economic Decision Analysis

    Jan 1, 2013, 00:00

  • Identifying Differential Responders and Their Characteristics in Clinical Trials- Innovative Methods for Analyzing Longitudinal Data

    Jan 1, 2013, 00:00

  • Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales- A Common Factor Model

    Jan 1, 2013, 00:00

  • Cost-Effectiveness Analysis- Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists

    Jan 1, 2013, 00:00

  • Cost-Effectiveness of Gene-Expression Profiling for Tumor-Site Origin

    Jan 1, 2013, 00:00

  • Copyright/Subscription

    Jan 1, 2013, 00:00

  • Whole Disease Modeling to Inform Resource Allocation Decisions in Cancer- A Methodological Framework

    Dec 1, 2012, 00:00

  • The Use of Qualitative Methods in Developing the Descriptive Systems of Preference-Based Measures of Health-Related Quality of Life for Use in Economic Evaluation

    Dec 1, 2012, 00:00

  • Cost-Effectiveness of Using a Molecular Diagnostic Test to Improve Preoperative Diagnosis of Thyroid Cancer

    Dec 1, 2012, 00:00

  • Preferences for Managing Symptoms of Differing Severity- A Discrete Choice Experiment

    Dec 1, 2012, 00:00

  • What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward

    Dec 1, 2012, 00:00

  • Demonstrating the Burden of Hypoglycemia on Patients' Quality of Life in Diabetes Clinical Trials- Measurement Considerations for Hypoglycemia

    Dec 1, 2012, 00:00

  • Table of Contents

    Dec 1, 2012, 00:00

  • Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values- Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D

    Dec 1, 2012, 00:00

  • Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals- Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Manag ...

    Dec 1, 2012, 00:00

  • Work Productivity in Relapsing Multiple Sclerosis- Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life

    Dec 1, 2012, 00:00

  • Measuring and Valuing Health Benefits for Economic Evaluation in Adolescence- An Assessment of the Practicality and Validity of the Child Health Utility 9D in the Australian Adolescent Population

    Dec 1, 2012, 00:00

  • Rank Reversal in Indirect Comparisons

    Dec 1, 2012, 00:00

  • Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research- A Report of the ISPOR Personalized Medicine Special Interest Group

    Dec 1, 2012, 00:00

  • The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

    Dec 1, 2012, 00:00

  • Comparing 15D and SF-6D Performance in Fragility Wrist and Hip Fracture Patients in a Two-Year Follow-Up Case-Control Study

    Dec 1, 2012, 00:00

  • Inquiry into the Relationship between Equity Weights and the Value of the QALY

    Dec 1, 2012, 00:00

  • Measuring Health-Related Quality of Life in Leukemia- The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire

    Dec 1, 2012, 00:00

  • Instructions for Authors

    Dec 1, 2012, 00:00

  • Patient-Level Hospital Costs and Length of Stay After Conventional Versus Minimally Invasive Total Hip Replacement- A Propensity-Matched Analysis

    Dec 1, 2012, 00:00

  • Multiple Criteria Decision Analysis for Health Technology Assessment

    Dec 1, 2012, 00:00

  • Budget Impact Analysis of HIV Testing in the VA Healthcare System

    Dec 1, 2012, 00:00

  • Contingent Valuation Scenarios for Chronic Illnesses- The Case of Childhood Asthma

    Dec 1, 2012, 00:00

  • Editorial Board

    Dec 1, 2012, 00:00

  • What Is Wrong with Orphan Drug Policies?

    Dec 1, 2012, 00:00

  • Development of the Shortness of Breath with Daily Activities Questionnaire (SOBDA)

    Dec 1, 2012, 00:00

  • A Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients with T3, Stage II Colon Cancer- Impact on Quality-Adjusted Life Expectancy and Costs

    Dec 1, 2012, 00:00

  • Copyright/Subscription

    Dec 1, 2012, 00:00

  • Unidimensional 12-Item Zarit Caregiver Burden Interview for the Assessment of Dementia Caregivers’ Burden Obtained by Item Response Theory

    Dec 1, 2012, 00:00

  • Comparison of Generic, Condition-Specific, and Mapped Health State Utility Values for Multiple Myeloma Cancer

    Dec 1, 2012, 00:00

  • PRS25 Cost Analysis of Omalizumab Use in Patients With Severe Uncontrolled Asthma Within the Mexican Public Health Care System

    Nov 1, 2012, 00:00

  • PRM40 Applying Stratification on Time to Overcome Time-Varying Covariates Effects in Cox Proportional Hazards Models

    Nov 1, 2012, 00:00

  • PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland

    Nov 1, 2012, 00:00

  • PHP63 Integrated Medication Reconciliation Model in Computerized Physician Order Entry (CPOE) System

    Nov 1, 2012, 00:00

  • PDB35 Evaluation of the Long Term Economic Impact of Improving Hba1C in Type 2 Diabetes Patients in Saudi Arabia

    Nov 1, 2012, 00:00

  • HT3 Development of a Check List for Quality Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Taiwan

    Nov 1, 2012, 00:00

  • PRM26 Comparison of Three Medication Adherence Measures in Patients Taking Warfarin

    Nov 1, 2012, 00:00

  • PSS30 Cosmeceutiqol- A Dermo-Cosmetic Quality-of-Life Assessment Tool

    Nov 1, 2012, 00:00

  • PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada

    Nov 1, 2012, 00:00

  • PHP77 Pharmaceutical Benefit Advisory Committee Acceptability Threshold Results 2005-2011

    Nov 1, 2012, 00:00

  • PRM83 Comparing Methods of Mixed Treatment Comparisons in Health Economic Models

    Nov 1, 2012, 00:00

  • PND49 The Measurement of Quality of Life in Children With Cystic Fibrosis With Using Russian Version of Health Utility Index (HUI) Questionnaire

    Nov 1, 2012, 00:00

  • PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

    Nov 1, 2012, 00:00

  • PSS35 Frequency of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration- Canadian Real-World Utilization Data

    Nov 1, 2012, 00:00

  • PHP13 Affordability of Antibacterial Medicines in Iran During 2001-2010

    Nov 1, 2012, 00:00

  • PUK11 Cost-Effectivness Analysis of Once Daily Versus Twice Daily Tacrolimus in Post-Renal Transplant Patients in the Czech Republic

    Nov 1, 2012, 00:00

  • PMH36 Time Trade-Off (TTO) Analysis to Elicit Health State Utilities Related to Long Acting Treatments in Schizophrenia

    Nov 1, 2012, 00:00

  • Ex2 An Observation on the Trend of Outpatient Clinic Utilization and Numbers of Medical Prescription Given in Taiwan Elderly Between 1997 and 2010

    Nov 1, 2012, 00:00

  • PHS51 Hospital Stays of Multiple Sclerosis Patients in Germany – Reasons, Frequencies, Duration and Impact on Drug Therapy

    Nov 1, 2012, 00:00

  • PMH6 Evolution of Antidepressant Efficacy Over Time- Illustration With Escitalopram

    Nov 1, 2012, 00:00

  • PRM14 European Assessment of the Validity of the QALY Outcome Measure- Results From the Experiment Conducted by the Echoutcome Project

    Nov 1, 2012, 00:00

  • PMH38 Assessing Depressive Symptoms in Primary Care- Psychometrical Properties of the Spanish Version of the Clinically Useful Depression Outcome Scale

    Nov 1, 2012, 00:00

  • PND38 Cost Minimization Analysis of Fingolimod Versus Natalizumab in the Second-Line Treatment of Remittent-Recurrent Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PIH40 What Do Health Economists Expect from Their Employer- Results from an On-Line Survey in Germany

    Nov 1, 2012, 00:00

  • PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM)- Pilot Data From the Initiator Study

    Nov 1, 2012, 00:00

  • PRM152 Is it Just Semantics? The Use of “Efficacy” and “Effectiveness” in Comparative Effectiveness Reviews and Health Technology Assessments

    Nov 1, 2012, 00:00

  • CV3 Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the UK

    Nov 1, 2012, 00:00

  • PMH9 Antidepressant Prescription Patterns Among Patients With Major Depression Based on Claims Database in Japan

    Nov 1, 2012, 00:00

  • PIN11 Pharmacotherapy of Acute Bronchitis in Clinics- Results of Pharmacoepidemical Research

    Nov 1, 2012, 00:00

  • PMD86 Inappropriate Use of Upper Gastrointestinal Endoscopy in Clinical Practices in Japan

    Nov 1, 2012, 00:00

  • PHP53 Identification of Factors Affecting the Medicine Expenditures in Public Hospital in Malaysia

    Nov 1, 2012, 00:00

  • PHP96 National Health Insurance Claims Database As a Valuable Source of Information for Health Technology Assessment in Taiwan

    Nov 1, 2012, 00:00

  • PRM9 Using Propensity Score Matching to Estimate the Resource Burden of Hospital Acquired Clostridium Difficile Infection in England

    Nov 1, 2012, 00:00

  • PHP189 Trends in the Use of Innovative Contracting Models Between the Pharmaceutical Industry and Payers in Europe

    Nov 1, 2012, 00:00

  • PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

    Nov 1, 2012, 00:00

  • PRM92 Exploratory Mapping of the LupusQol to the SF-6D

    Nov 1, 2012, 00:00

  • PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registries

    Nov 1, 2012, 00:00

  • PHP133 Market Access of Drugs in France and Medico-Economic Assessment

    Nov 1, 2012, 00:00

  • PCV4 Comparative Effectiveness Research of Fondaparinux and Enoxaparin in St-Elevated Acute Coronary Syndrome Patients Receiving Fibrinolytic Therapy- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PMS70 Utilization of Pain Medications Among Osteoarthritis Patients Who Initiated Duloxetine and Standard of Care for Pain Management

    Nov 1, 2012, 00:00

  • PHP20 Analysis of How Payers Incorporate Health Economic Analyses Into Coverage and HTA Decisions for Personalized Medicine Diagnostics

    Nov 1, 2012, 00:00

  • PMD50 Cost-Effectiveness Analysis of Four Validated Techniques of Accelerated Partial Breast Irradiation for the Treatment of Early-Stage Breast Cancer- Spanish Public Health System Standard Estimations

    Nov 1, 2012, 00:00

  • PMH2 Value of Agomelatine in the Treatment of Depressive Disorders in Thailand

    Nov 1, 2012, 00:00

  • PMD85 Agent-Based Cardiovascular Disease Model for India

    Nov 1, 2012, 00:00

  • PIN69 Cost Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in Malaysia

    Nov 1, 2012, 00:00

  • RE3 How Will the New NHS Changes in England Impact the Implementation of Risk-Sharing Schemes for Oncology Treatments?

    Nov 1, 2012, 00:00

  • PSY34 Understanding Disease Presentation and Patient-Reported and Economic Impact of Herpes Zoster (HZ) and Post-Herpetic Neuralgia (PHN)- Findings From the Zoster Quality of Life (ZQOL) Study

    Nov 1, 2012, 00:00

  • PRS10 Assessment of Knowledge Regarding Tuberculosis Among General Population in North East Libya

    Nov 1, 2012, 00:00

  • PHP83 Community Pharmacist'S Perceptions Towards the Quality of Locally Manufactured Generic Medicines- A Descriptive Study from Malaysia

    Nov 1, 2012, 00:00

  • PHS72 Quality of Life With Type2 Diabetes- Translation and Validation of Indian Version of MDQ

    Nov 1, 2012, 00:00

  • PRM178 Excel to Mobile- The Method for Automated Migration of Excel-Based Markov Models to Modern Software Platforms

    Nov 1, 2012, 00:00

  • PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical Assets

    Nov 1, 2012, 00:00

  • PHP149 Health Technology Assessment Evidence Criteria- What Types of Evidence Should Be Presented for Products Used to Screen for Disease in the United States?

    Nov 1, 2012, 00:00

  • PRM163 The Use of Expected Value of Perfect Information Analysis Within Economic Evaluations and Health Technology Assessments in the UK

    Nov 1, 2012, 00:00

  • PND1 Prescribing Patterns of Z-Drugs Among Geriatric Patients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PRM17 Cost-Utility Analysis of Donepezil for the Treatment of Alzheimer's Disease in Thailand

    Nov 1, 2012, 00:00

  • PGI39 Budegt Impact Analysis of HCV Therapy Cost After Boceprevir Addition to Standard Therapeutic Regime

    Nov 1, 2012, 00:00

  • PRM8 Costing Issue in Pharmacoeconomic Studies from the Perspective of Singapore Public Health Care Provider

    Nov 1, 2012, 00:00

  • MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer Treatment

    Nov 1, 2012, 00:00

  • PHP89 Market Access of Drugs in Fran Evolution or Revolution?

    Nov 1, 2012, 00:00

  • PRM67 The Use of Health Economic Models in Hungarian Health Technology Assessment

    Nov 1, 2012, 00:00

  • PHP70 A 3-Year Follow-Up Study on National Health Insurance Reimbursements Among Atrial Fibrillation Patients With/Without Stroke in Taiwan- A Population-Based Study

    Nov 1, 2012, 00:00

  • PGI8 Second and Third Generation FVIII Treatment Resources Consumption Break-Even Point- The Pass Study Results

    Nov 1, 2012, 00:00

  • PND41 The Cost-Effectiveness of Buccolam for the Treatment of Prolonged, Acute, Convulsive Epileptic Seizures in Spain

    Nov 1, 2012, 00:00

  • PHS20 Cost Associated to the Management of Inappropriate Shocks in Patients With an Implantable Cardioverter Defibrillator – Cardina Study

    Nov 1, 2012, 00:00

  • PUK8 4-Year Incidence and Costs of Hospitalized Complications Within Kidney Transplant Patients in France

    Nov 1, 2012, 00:00

  • PHS19 Macro-Costing Analysis of Hospital Stay in Heart Failure Patients in Turkish Setting

    Nov 1, 2012, 00:00

  • PSY8 Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Thailand

    Nov 1, 2012, 00:00

  • PRM95 Does the Cat Questionnaire Produce Similar Results When Self- or Interviewer-Administered?

    Nov 1, 2012, 00:00

  • PIN14 Projecting the Clinical Impact of Treating Hepatitis C Genotype 1 Infection With Boceprevir in Germany

    Nov 1, 2012, 00:00

  • PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing Regimen

    Nov 1, 2012, 00:00

  • PHP175 Economic Performance and Epidemiological Transition in Mexico

    Nov 1, 2012, 00:00

  • PHP42 Do Macroeconomic Conditions Explain Drug Price Variations Across Countries? A Cross-Sectional Analysis

    Nov 1, 2012, 00:00

  • PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective

    Nov 1, 2012, 00:00

  • PDB57 Patients' Preferences for Attributes of Type 2 Diabetes Medications- A Conjoint Analysis

    Nov 1, 2012, 00:00

  • PMH7 Analyses of Switching and Combination Use of Antidepressants in Young Swedish Adults

    Nov 1, 2012, 00:00

  • PHP97 Identifying Modeling Factors Influencing Coverage Decisions by Nice in 10 Single Technology Appraisals (STA) of Expensive Drugs

    Nov 1, 2012, 00:00

  • PCN110 Differences in Health-Related Quality of Life Between Children Treated for Acute Lymphoblastic Leukemia (ALL) on Dana Farber Cancer Institute (DFCI) Protocols

    Nov 1, 2012, 00:00

  • PIH51 Review of All Products Authorized by the European Medicines Agency from 1995 to 2011 in Regard to Pediatric Investigation Plan Applications

    Nov 1, 2012, 00:00

  • PMH52 Health Care Resource Utilization and Costs for Patients With Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder

    Nov 1, 2012, 00:00

  • PRM45 Are Minimal Clinically Important Difference Measures (MCIDs) Relevant for Survival Outcomes? Introducing the MCID-CAC

    Nov 1, 2012, 00:00

  • PHP24 Should Pharmacist Remuneration Systems in Europe Be Reformed in Order to Increase Generic Medicine Dispensing?

    Nov 1, 2012, 00:00

  • PND43 Cost-Utility Analysis Patients With Low Back Pain After Treatment Intraosseous Blockades

    Nov 1, 2012, 00:00

  • HC2 A Review of Economic Evaluations of New Drugs Priced by the Similar Drug Comparison Method in Japan- Did Cost-Effectveness Results Justify Premiums?

    Nov 1, 2012, 00:00

  • PHP191 Impact of a Financial Risk-Sharing Scheme on Budget-Impact Estimations- A Game-Theoretic Approach

    Nov 1, 2012, 00:00

  • PMD36 Cost-Analysis of PCR Guided Pre-Emptive Antibiotic Treatment of S.aureus-infections- An Analytic Decision Model

    Nov 1, 2012, 00:00

  • CN2 How Early-Stage Non-Persistence and Non-Adherence to Adjuvant Hormonal Therapy Associated With Postmenopausal Breast Cancer Mortality in Taiwan

    Nov 1, 2012, 00:00

  • PHP9 Assessment of Diagnostic Need for Magnetic Resonance Imaging in Medicare Patients with Pacemaker Implants

    Nov 1, 2012, 00:00

  • PHP25 The Pharmaceutical Industry as Partner in Integrated Care Contracts - Potential Improvement or Vain Attempt? First Experiences from Germany

    Nov 1, 2012, 00:00

  • PHP6 The Study of Antihyperglycemic Drug Use Patterns and the Toward Clinical Excellence Network'S Diabetes (TCEN DM) Indicators in Patients with Type 2 Diabetes Mellitus at Samutsakhon Hospital

    Nov 1, 2012, 00:00

  • PDB43 Economic Evaluation of Vildagliptin Compared to Glimepiride as Add-on to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Greece

    Nov 1, 2012, 00:00

  • PCV33 Self-Reported Health Status Among Taiwanese Hypertensive Elderly

    Nov 1, 2012, 00:00

  • PDB23 Economic Impact of Analogue Insulin on Health Expenditure at the Mexican Institute of Social Security in 2012. An Expenditure Reduction Proposal

    Nov 1, 2012, 00:00

  • PMD18 Introduction of Novel Biomarker Testing for Ovarian Cancer- Budget Impact Analysis for an Italian Regional Health Care Service

    Nov 1, 2012, 00:00

  • PGI30 Assessment of Practice Patterns and Treatment-Failure Costs Among Patients With Irritable Bowel Syndrome With Constipation- Findings From a Physician Survey Study

    Nov 1, 2012, 00:00

  • PCV59 Where Did the Time Go?- Temporal Uncertainty in Cost-Effectiveness Decision Models

    Nov 1, 2012, 00:00

  • PMD13 Projected Economic Impact of Utilizing Fractional Flow Reserve (FFR)-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Interventions (PCI) in Patients With Multivessel Coronary Disease- A Budget Impact Model

    Nov 1, 2012, 00:00

  • PHP33 Drug-Related Problems and Length of Stay in the Management of Infection in Patients with Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PCV27 Cost-Effectiveness of Left Atrial Appendage Occlusion Device for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM154 Source Data Verification – A Survey of Current Practice

    Nov 1, 2012, 00:00

  • PCV29 Long-Term Cost-Effectiveness of Ticagrelor in Patients with Acute Coronary Syndrome in Thailand

    Nov 1, 2012, 00:00

  • PMS13 Cost-Effectiveness of Biological Treatments in Patients with Rheumatoid Arthritis in Taiwan

    Nov 1, 2012, 00:00

  • PCV113 The Utilisation of Statins in Slovak Republic

    Nov 1, 2012, 00:00

  • PND53 Patient Reported Sleep Problems in the UK

    Nov 1, 2012, 00:00

  • PCV109 Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain

    Nov 1, 2012, 00:00

  • PHP165 Exploring the Role of the Committee in the Nice Appraisal Process- How Consistent are Decisions Across Committees?

    Nov 1, 2012, 00:00

  • PMD77 Contribution of Individual EQ-5D Dimensions to Improved Quality of Life After Balloon Kyphoplasty for Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PSY20 Cost-Effectiveness of Prophylaxis With an Anti-Inhibitor Complex Concentrate in Patients With Haemophilia and Inhibitors- Results From Pro-Feiba Study

    Nov 1, 2012, 00:00

  • PCN113 Assessing Health-Related Quality of Life (HRQoL) for Advanced Basal Cell Carcinoma (aBCC) and Basal Cell Carcinoma Nevus Syndrome (BCCNS)- Development of the First Disease-Specific Patient-Reported Outcome (PRO) Questionnaire

    Nov 1, 2012, 00:00

  • PRS28 Cost-Effectiveness Analysis of Montelukast in 6-14-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus

    Nov 1, 2012, 00:00

  • PIN30 Varicella, a Cost of Illness Hungarian Study

    Nov 1, 2012, 00:00

  • PCN23 Cancer Related Bisphosphonate Therapy in Different Treatment Facilities

    Nov 1, 2012, 00:00

  • PCV41 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Knee Replacement

    Nov 1, 2012, 00:00

  • PSU12 Minimally Invasive Surgery in Spinal Fusion - Clinical and Economical Impact From Hospital Perspective

    Nov 1, 2012, 00:00

  • CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves

    Nov 1, 2012, 00:00

  • PMS68 The Use of Monitoring Systems to Better Regulate Drug Consumption in Hungarian Hospitals

    Nov 1, 2012, 00:00

  • PRM61 External Validation of a Cardio-Vascular Disease Model

    Nov 1, 2012, 00:00

  • PCN124 Lost Productivity in Population of Cancer Patient's Close Relatives in Poland

    Nov 1, 2012, 00:00

  • PA4 Home Dialysis- How High can we go?

    Nov 1, 2012, 00:00

  • PR1 Comparison of Cancer Drug Prices in the United States and the Uk

    Nov 1, 2012, 00:00

  • PHP57 Clinical Effects of Pharmacist Interventions for Polypharmacy in a Geriatric Clinic in Taiwan

    Nov 1, 2012, 00:00

  • PHP62 A Novel Global Health Drug Subsidy AMFm- Assessment of Deployment in Southern Ghana

    Nov 1, 2012, 00:00

  • PCN131 Pricing Theory and Reality- The Link Between Outcomes and Price

    Nov 1, 2012, 00:00

  • PDB36 An Evaluation of the Long-Term Costs and Effects of a 1% Reduction in HbA1C in Type 2 Diabetes Patients in Malaysia

    Nov 1, 2012, 00:00

  • PHP119 Value and the Multiple Criteria Used in OECD Countries' Medicine Reimbursement Decision-Making Processes Using Health Economic Evidence

    Nov 1, 2012, 00:00

  • PCN139 Characteristics of Long-Acting Somatostatin (SSA) Use in Gastro-Entero-Pancreatic Neuroendocrine (GEP-NET) Tumors in the Netherlands

    Nov 1, 2012, 00:00

  • PDB11 A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues

    Nov 1, 2012, 00:00

  • PMH39 Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses From Semi-Structured Qualitative Interviews in Patients With Major Depressive Disorder

    Nov 1, 2012, 00:00

  • PRS36 Content Validity of Two Symptom Questionnaires for Idiopathic Pulmonary Fibrosis

    Nov 1, 2012, 00:00

  • PDB73 Obesity and Frequent Hypoglycemia in European Type 2 Diabetes Patients

    Nov 1, 2012, 00:00

  • PHP16 Generic Drug Market Access in Japan

    Nov 1, 2012, 00:00

  • PRM35 Prevalence of Rare Diseases – A Special Challenge for Benefit Assessment and Health Economics

    Nov 1, 2012, 00:00

  • PMH4 Pharmacoepidemiology of Antidepressants in Elderly Patients- 12 Years of Experience

    Nov 1, 2012, 00:00

  • PIH1 Spontaneous Adverse Drug Reactions Reporting Forms of 55 Different Countries – Evaluation, Comparison, and Quality Check

    Nov 1, 2012, 00:00

  • PRM29 Suprapubic Prostatectomy (SP) Versus Transurethral Endoscopic Resection of Prostate (TURP)- Hospitalization Outcomes and Costs of Benign Prostatic Hyperplasia Using a Prublic Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • CN4 Inpatient Treatment Patterns and Health Care Expenditures for Hepatocellular Carcinoma Among Population With Urban Basic Health Insurance in China

    Nov 1, 2012, 00:00

  • PMS51 Work Productivity and Productivity Costs of Patients With Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis in the Czech Republic

    Nov 1, 2012, 00:00

  • PIH9 Assosiation Between Health Care Providers and Immunization Compliance in Iraq

    Nov 1, 2012, 00:00

  • MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression

    Nov 1, 2012, 00:00

  • PCN38 Impact of Biomarker Testing on Clinical and Economic Outcomes in Advanced Cancer Treatment

    Nov 1, 2012, 00:00

  • PMD52 Diagnostics in Cost-Effectiveness Analysis- The Evaluation of the EOS 2D/3D X-Ray Imaging System

    Nov 1, 2012, 00:00

  • PRM153 Prioritizing Multiple Patient-Relevant Endpoints - a Methodological Comparison of Conjoint Analysis and Analytic Hierarchy Process Considering IQWiG‘s Efficiency Frontier Concept

    Nov 1, 2012, 00:00

  • PSU28 Retrospective Analysis of Liver Transplantation in Brazil

    Nov 1, 2012, 00:00

  • PMS14 Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in China

    Nov 1, 2012, 00:00

  • PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

    Nov 1, 2012, 00:00

  • PHS26 Economic Burden of Seasonal Influenza B in France During Winter 2010-2011

    Nov 1, 2012, 00:00

  • PRS34 Australian New to Therapy Program Improves Tiotropium (Spiriva) Persistence and Compliance

    Nov 1, 2012, 00:00

  • PDB21 Chart Audit and Budget Impact Analysis of Pasireotide Versus Second-Line Therapies in the Treatment of Cushing's Disease in Germany

    Nov 1, 2012, 00:00

  • PMS7 The Medication Costs of Rheumatoid Arthritis - Comparing Before and After Introduction of the Biologics

    Nov 1, 2012, 00:00

  • PRM8 Treatment of Rheumatoid Arthritis – Comparative Effectiveness of Biologics

    Nov 1, 2012, 00:00

  • PHP37 Prescription Switching from Angiotensin-Converting Enzyme Inhibitors to Angiotensin Receptor Blockers in Taiwan

    Nov 1, 2012, 00:00

  • PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma

    Nov 1, 2012, 00:00

  • PRS35 The Economic Burden of HAE- Findings From the HAE Burden of Illness Study in Europe (HAE-BOIS-Europe)

    Nov 1, 2012, 00:00

  • PDB27 Cost-Utility Analysis of Liraglutide Versus Glimepiride As Add-on to Metformin in Patients with Type 2 Diabetes in China

    Nov 1, 2012, 00:00

  • PND2 Effect of Cognitive Behavioural Therapy in Multiple Sclerosis Fatigue- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2012, 00:00

  • PMH32 Modelling the Cost and Effectiveness Outcomes Associated With Different Sequences for the Treatment of Chronic Schizophrenia- An Economic Evaluation of Paliperidone Palmitate

    Nov 1, 2012, 00:00

  • PCN4 Role of 5-Alpha-Reductase Inhibitors, Statins, Aspirin, Nsaids on the Development of Prostate Cancer in Benign Prostatic Hyperplasia Patients-a Population Based Study

    Nov 1, 2012, 00:00

  • PDB50 Health Care Resource Utilization in the Management of Cushing Disease- An Analysis From South-Western Ontario

    Nov 1, 2012, 00:00

  • PR3 Drivers of Pricing and Market Access Decisions - Examples in Selected Countries

    Nov 1, 2012, 00:00

  • PHS55 Inequalities and Avoidable Costs of Imaging Test in the Diagnosis and Monitoring of Patients With Stroke in the Canary Islands

    Nov 1, 2012, 00:00

  • PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting

    Nov 1, 2012, 00:00

  • PUK2 Economic Burden of Hemodialysis and Peritoneal Dialysis in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PGI3 Treatment of Chronic Hepatitis C Genotype 1 in Poland – Real-Life Data

    Nov 1, 2012, 00:00

  • PIH13 The Costs of Unintended Pregnancy in Russia

    Nov 1, 2012, 00:00

  • HT4 Health Technology Assessment Map in Asia – Regional Versus International Influences

    Nov 1, 2012, 00:00

  • PCN70 The Cost Effectiveness of Degarelix for the Treatment of Prostate Cancer in the UK

    Nov 1, 2012, 00:00

  • PIN78 Treatment Preference Attributes Among Primary Immunodeficiency Patients and Caregivers Receiving Immunoglobulin Therapy

    Nov 1, 2012, 00:00

  • PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM157 Methodological Challenges of IQWiG's Efficiency Frontier Concept Elicited by Multiple Patient-Relevant Endpoints – Why Prioritization of Endpoints Cannot Be Avoided

    Nov 1, 2012, 00:00

  • PHP38 Point-of-Care Diagnostic Test Reimbursement and Market Access- Lessons from a Survey of Global Health Technology Assessments

    Nov 1, 2012, 00:00

  • PIN5 Immune Reconstitution Inflammatory Syndrome (IRIS) Incidence in Patients Starting Antiretroviral Therapy (ART) Eartlier Versus Later During Tuberculosis (TB) Therapy- A Systemic Review and Meta-Analysis of Cohort Sutdies

    Nov 1, 2012, 00:00

  • PRS45 Health Outcomes and Costs of Patients With Chronic Obstructive Pulmonary Disease According to the Continuity of Ambulatory Care With Korean National Health Insurance Database

    Nov 1, 2012, 00:00

  • PCN59 Patterns of Clinical Management and Resource Utilization for Postmenopausal Hormone Receptor–Positive HER2-Negative (HR+ HER2–) Advanced Breast Cancer (ABC) in Europe

    Nov 1, 2012, 00:00

  • PIN41 Cost-Effectiveness of Pertussis Adolescent Booster in England and Wales- A Dynamic Model Based Analysis

    Nov 1, 2012, 00:00

  • PSY31 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Hip Fracture Patients

    Nov 1, 2012, 00:00

  • PGI13 Economic Burden and Treatment Patterns of Adult Patients With Chronic Constipation Identified Through Retrospective Database Research

    Nov 1, 2012, 00:00

  • PSU24 The Equivalence of Remote Electronic and Paper Collection of Patient Reported Outcomes (PROS)- A Crossover Trial

    Nov 1, 2012, 00:00

  • PSY14 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Fibromyalgia

    Nov 1, 2012, 00:00

  • PIN8 A Preliminary Economical Analysis Based on the Early Impact Observed on Genital Warts Burden Reduction Following Quadrivalent HPV Vaccination in Belgium

    Nov 1, 2012, 00:00

  • PSU27 Liver Transplantation in Familial Amyloid Polyneuropathy in Brazil- Demographic and Clinical Data Compared to FAP World Transplant Registry

    Nov 1, 2012, 00:00

  • PMH14 Resilience Resources Predict Higher Quality of Life (QOL) Among Taiwanese Dialysis Patients

    Nov 1, 2012, 00:00

  • PMS48 Tocilizumab in Methotrexate-Intolerant or Contraindicated Patients – A Cost-Utility Model for the UK

    Nov 1, 2012, 00:00

  • PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up

    Nov 1, 2012, 00:00

  • PSU34 Epidemiological Modeling of Patient Survival After Liver Transplantation in Germany

    Nov 1, 2012, 00:00

  • PHP102 Patient Satisfaction with Pharmacies Condition

    Nov 1, 2012, 00:00

  • PHS52 Estimating the Resources Needed to Implement a Population-Based Colorectal Cancer Screening Program Through Discrete Event Simulation

    Nov 1, 2012, 00:00

  • PMD22 Financial Impact of Adopting Implantable Loop Recorder (ILR) Diagnostics (REVEAL®) for Unexplained Syncope in Portugal- Comparison With Conventional Diagnostic Pathways

    Nov 1, 2012, 00:00

  • PHP34 The Clinical Effectiveness and Resource Utilization of Drugs Which Contain Herbal Extracts – the Examples on Silymarin

    Nov 1, 2012, 00:00

  • PSY2 Effect of Intravenous Parecoxib on Postoperative Pain Relief After Total Knee Arthroplasty

    Nov 1, 2012, 00:00

  • PHP46 Burden of Herpes Zoster in Population with Compromised Immune System in South Korea

    Nov 1, 2012, 00:00

  • PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in China

    Nov 1, 2012, 00:00

  • PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)

    Nov 1, 2012, 00:00

  • PCN15 Clinical and Cost-Effectiveness of Proton Beam Radiotherapy for Eye Cancer- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP79 Stakeholders's Views Regarding the Impact of Financial Crisis on the Pharmaceutical Market in Greece

    Nov 1, 2012, 00:00

  • PIN83 National Immunization Technical Advisory Group (NITAG) Decision-Making Process for Vaccine Recommendation- Overview and Analysis

    Nov 1, 2012, 00:00

  • CV1 Cost-Effectiveness of a Nurse Facilitated Self-Management Programme for Heart Failure

    Nov 1, 2012, 00:00

  • PRS38 Turkish Cultural Adaptation and Validation of Smoking Cessation Quality of Life (SCQoL) Questionnaire

    Nov 1, 2012, 00:00

  • PHP159 Proposed and Actual Bureaucratic Burden of HTA Submissions to the Industry- Case Studies from Germany and UK

    Nov 1, 2012, 00:00

  • PRM132 Using Clinical Outcome Assessments and Economic Data to Facilitate Patient Access in Rheumatoid Arthritis

    Nov 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124 (current)
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »